GlaxoSmithKline Pharmaceuticals Limited (GLAXO) — Cash Flow-to-Debt Ratio
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2023, meaning its operating cash flow of Rs362.20 Million could theoretically repay 0% of its total liabilities (Rs17.31 Billion) in one year. See GLAXO free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
GlaxoSmithKline Pharmaceuticals Limited Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for GlaxoSmithKline Pharmaceuticals Limited across 21 annual periods. Also explore net asset growth rate of GlaxoSmithKline Pharmaceuticals Limited to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for GlaxoSmithKline Pharmaceuticals Limited (2005–2025)
Year-by-year debt coverage analysis for GlaxoSmithKline Pharmaceuticals Limited. For market capitalisation and broader financial context, see GLAXO market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.60x | Rs12.90 Billion | Rs21.57 Billion | ▲ +82.8% |
| 2024 | 0.33x | Rs5.82 Billion | Rs17.79 Billion | ▲ +7.1% |
| 2023 | 0.31x | Rs4.84 Billion | Rs15.85 Billion | ▼ -25.8% |
| 2022 | 0.41x | Rs8.11 Billion | Rs19.70 Billion | ▲ +14.9% |
| 2021 | 0.36x | Rs5.78 Billion | Rs16.14 Billion | ▼ -4.0% |
| 2020 | 0.37x | Rs4.90 Billion | Rs13.15 Billion | ▲ +65.5% |
| 2019 | 0.23x | Rs3.99 Billion | Rs17.71 Billion | ▼ -9.9% |
| 2018 | 0.25x | Rs4.73 Billion | Rs18.90 Billion | ▲ +5.7% |
| 2017 | 0.24x | Rs2.36 Billion | Rs9.97 Billion | ▲ +129.6% |
| 2016 | 0.10x | Rs1.39 Billion | Rs13.50 Billion | ▼ -70.2% |
| 2015 | 0.35x | Rs2.70 Billion | Rs7.80 Billion | ▲ +40.2% |
| 2014 | 0.25x | Rs2.81 Billion | Rs11.40 Billion | ▼ -14.9% |
| 2013 | 0.29x | Rs3.14 Billion | Rs10.82 Billion | ▼ -2.4% |
| 2012 | 0.30x | Rs3.36 Billion | Rs11.30 Billion | ▼ -46.8% |
| 2011 | 0.56x | Rs4.79 Billion | Rs8.59 Billion | ▼ -22.3% |
| 2010 | 0.72x | Rs5.12 Billion | Rs7.12 Billion | ▲ +62.2% |
| 2009 | 0.44x | Rs3.30 Billion | Rs7.45 Billion | ▼ -9.0% |
| 2008 | 0.49x | Rs3.19 Billion | Rs6.55 Billion | ▲ +10.0% |
| 2007 | 0.44x | Rs2.59 Billion | Rs5.84 Billion | ▼ -28.7% |
| 2006 | 0.62x | Rs3.49 Billion | Rs5.63 Billion | ▲ +32.9% |
| 2005 | 0.47x | Rs2.29 Billion | Rs4.90 Billion | — |